ICSMA-20-079-01
Vulnerability from csaf_cisa - Published: 2020-03-19 00:00 - Updated: 2020-03-19 00:00| Product | Identifier | Version | Remediation |
|---|---|---|---|
|
Omnipod Insulin Management System: UDI/Model/NDC number ZXP425 (10-Pack) and ZXR425 (10-Pack Canada)
Insulet / Omnipod Insulin Management System
|
UDI/Model/NDC number ZXP425 (10-Pack) | ZXR425 (10-Pack Canada) |
Vendor Fix
Vendor Fix
fix
Vendor Fix
fix
|
|
|
Omnipod Insulin Management System: Product ID/Reorder number 19191 and 40160
Insulet / Omnipod Insulin Management System
|
Product ID/Reorder number 19191 | 40160 |
Vendor Fix
Vendor Fix
fix
Vendor Fix
fix
|
{
"document": {
"acknowledgments": [
{
"organization": "Thirdwayv Inc",
"summary": "reporting this vulnerability to Insulet"
},
{
"organization": "Insulet",
"summary": "reporting this vulnerability to CISA"
}
],
"category": "csaf_security_advisory",
"csaf_version": "2.0",
"distribution": {
"text": "Disclosure is not limited",
"tlp": {
"label": "WHITE",
"url": "https://us-cert.cisa.gov/tlp/"
}
},
"lang": "en-US",
"notes": [
{
"category": "general",
"text": "This CSAF advisory was extracted from unstructured data and may contain inaccuracies. If you notice any errors, please reach out to the designated contact at CISA CSAF: central@cisa.dhs.gov",
"title": "CISA Disclaimer"
},
{
"category": "legal_disclaimer",
"text": "All information products included in https://us-cert.cisa.gov/ics are provided \"as is\" for informational purposes only. The Department of Homeland Security (DHS) does not provide any warranties of any kind regarding any information contained within. DHS does not endorse any commercial product or service, referenced in this product or otherwise. Further dissemination of this product is governed by the Traffic Light Protocol (TLP) marking in the header. For more information about TLP, see https://us-cert.cisa.gov/tlp/.",
"title": "Legal Notice"
},
{
"category": "summary",
"text": "Successful exploitation of this vulnerability may allow an attacker to gain access to the affected products to intercept, modify, or interfere with the wireless RF (radio frequency) communications to or from the product. This may allow attackers to read sensitive data, change pump settings, or control insulin delivery.",
"title": "Risk evaluation"
},
{
"category": "other",
"text": "Healthcare and Public Health",
"title": "Critical infrastructure sectors"
},
{
"category": "other",
"text": "United States, Canada, Europe",
"title": "Countries/areas deployed"
},
{
"category": "other",
"text": "United States",
"title": "Company headquarters location"
},
{
"category": "general",
"text": "CISA recommends users take defensive measures to minimize the risk of exploitation of this vulnerability. Specifically, users should:",
"title": "Recommended Practices"
},
{
"category": "general",
"text": "CISA reminds organizations to perform proper impact analysis and risk assessment prior to deploying defensive measures.\nCISA also provides a section for control systems security recommended practices on the ICS webpage onus-cert.gov. Several recommended practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with Defense-in-Depth Strategies.",
"title": "Recommended Practices"
},
{
"category": "general",
"text": "Additional mitigation guidance and recommended practices are publicly available on the ICS webpage on us-cert.gov in the Technical Information Paper, ICS-TIP-12-146-01B--Targeted Cyber Intrusion Detection and Mitigation Strategies.\nOrganizations observing any suspected malicious activity should follow their established internal procedures and report their findings to CISA for tracking and correlation against other incidents.",
"title": "Recommended Practices"
},
{
"category": "general",
"text": "This vulnerability is not exploitable remotely.",
"title": "Recommended Practices"
}
],
"publisher": {
"category": "coordinator",
"contact_details": "Email: CISAservicedesk@cisa.dhs.gov;\n Toll Free: 1-888-282-0870",
"name": "CISA",
"namespace": "https://www.cisa.gov/"
},
"references": [
{
"category": "self",
"summary": "ICS Advisory ICSMA-20-079-01 JSON",
"url": "https://raw.githubusercontent.com/cisagov/CSAF/develop/csaf_files/OT/white/2020/icsma-20-079-01.json"
},
{
"category": "self",
"summary": "ICS Advisory ICSMA-20-079-01 Web Version",
"url": "https://www.cisa.gov/news-events/ics-medical-advisories/icsma-20-079-01"
},
{
"category": "external",
"summary": "Recommended Practices",
"url": "https://www.fda.gov/medical-devices/digital-health/cybersecurity"
},
{
"category": "external",
"summary": "Recommended Practices",
"url": "https://www.us-cert.gov/sites/default/files/recommended_practices/NCCIC_ICS-CERT_Defense_in_Depth_2016_S508C.pdf"
},
{
"category": "external",
"summary": "Recommended Practices",
"url": "https://www.us-cert.gov/ics/tips/ICS-TIP-12-146-01B"
}
],
"title": "Insulet Omnipod",
"tracking": {
"current_release_date": "2020-03-19T00:00:00.000000Z",
"generator": {
"engine": {
"name": "CISA CSAF Generator",
"version": "1.0.0"
}
},
"id": "ICSMA-20-079-01",
"initial_release_date": "2020-03-19T00:00:00.000000Z",
"revision_history": [
{
"date": "2020-03-19T00:00:00.000000Z",
"legacy_version": "Initial",
"number": "1",
"summary": "ICSMA-20-079-01 Insulet Omnipod"
}
],
"status": "final",
"version": "1"
}
},
"product_tree": {
"branches": [
{
"branches": [
{
"branches": [
{
"category": "product_version",
"name": "UDI/Model/NDC number ZXP425 (10-Pack) | ZXR425 (10-Pack Canada)",
"product": {
"name": "Omnipod Insulin Management System: UDI/Model/NDC number ZXP425 (10-Pack) and ZXR425 (10-Pack Canada)",
"product_id": "CSAFPID-0001"
}
}
],
"category": "product_name",
"name": "Omnipod Insulin Management System"
},
{
"branches": [
{
"category": "product_version",
"name": "Product ID/Reorder number 19191 | 40160",
"product": {
"name": "Omnipod Insulin Management System: Product ID/Reorder number 19191 and 40160",
"product_id": "CSAFPID-0002"
}
}
],
"category": "product_name",
"name": "Omnipod Insulin Management System"
}
],
"category": "vendor",
"name": "Insulet"
}
]
},
"vulnerabilities": [
{
"cve": "CVE-2020-10627",
"cwe": {
"id": "CWE-284",
"name": "Improper Access Control"
},
"notes": [
{
"category": "summary",
"text": "The affected insulin pump is designed to communicate using a wireless RF with an Insulet manufactured Personal Diabetes Manager device. This wireless RF communication protocol does not properly implement authentication or authorization. An attacker with access to one of the affected insulin pump models may be able to modify and/or intercept data. This vulnerability could also allow attackers to change pump settings and control insulin delivery.CVE-2020-10627has been assigned to this vulnerability. A CVSS v3 base score of 7.3 has been assigned; the CVSS vector string is (AV:L/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:L).",
"title": "Vulnerability Summary"
}
],
"product_status": {
"known_affected": [
"CSAFPID-0001",
"CSAFPID-0002"
]
},
"references": [
{
"category": "external",
"summary": "web.nvd.nist.gov",
"url": "http://web.nvd.nist.gov/view/vuln/detail?vulnId=CVE-2020-10627"
},
{
"category": "external",
"summary": "www.first.org",
"url": "https://www.first.org/cvss/calculator/3.0#CVSS:3.0/AV:L/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:L"
}
],
"remediations": [
{
"category": "vendor_fix",
"details": "Insulet recommends patients using the affected products talk to their healthcare provider about the risks of continued use, including the possibility of changing to the latest model with increased cybersecurity protection.\nAdditionally, Insulet recommends all patients take the cybersecurity precautions indicated below.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002"
]
},
{
"category": "vendor_fix",
"details": "Insulet has released additional patient-focused information.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002"
],
"url": "https://www.myomnipod.com/security-bulletins"
},
{
"category": "vendor_fix",
"details": "More information is available regarding Insulet \u0027s product security and vulnerability management.",
"product_ids": [
"CSAFPID-0001",
"CSAFPID-0002"
],
"url": "https://www.myomnipod.com/product-security"
}
],
"scores": [
{
"cvss_v3": {
"baseScore": 7.3,
"baseSeverity": "HIGH",
"vectorString": "CVSS:3.0/AV:L/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:L",
"version": "3.0"
},
"products": [
"CSAFPID-0001",
"CSAFPID-0002"
]
}
]
}
]
}
Drag nodes to arrange them. Double-click a related vulnerability to open it, or a source to visit its link. The Physics button on the left tunes the layout and the simulation; the legend at the bottom left hides or shows nodes by kind and by sighting type.
Sightings
| Author | Source | Type | Date | Other |
|---|
Nomenclature
- Seen: The vulnerability was mentioned, discussed, or observed by the user.
- Confirmed: The vulnerability has been validated from an analyst's perspective.
- Published Proof of Concept: A public proof of concept is available for this vulnerability.
- Exploited: The vulnerability was observed as exploited by the user who reported the sighting.
- Patched: The vulnerability was observed as successfully patched by the user who reported the sighting.
- Not exploited: The vulnerability was not observed as exploited by the user who reported the sighting.
- Not confirmed: The user expressed doubt about the validity of the vulnerability.
- Not patched: The vulnerability was not observed as successfully patched by the user who reported the sighting.
Vulnerability timeline
Sightings and recorded dates, grouped by day · UTC
How durations are calculated
Following the VTEM framework (Black Hat USA 2015), time to patch starts when the vendor or a coordinator was informed, total time to patch at discovery, and disclosure to patch at public disclosure; vendor response time runs from the report to its acknowledgement. Time to exploit and time unpatched start at the earliest discovery or report, falling back to public disclosure. Unpatched time ends at the first recorded patch, or the calculation time when no patch is recorded. Exploitation to patch shows the interval between those two events; a published proof of concept is a public exploit, not exploitation.
Each result shows its source dates. A negative interval means the end event came first; when date-only inputs leave the order open, the result says so. Date-only inputs are approximate. The earliest evidence wins: KEV report dates and sightings are labelled as such. Records describing another vulnerability are listed but never calculated from, and a PoC alone does not establish exploitation. Missing patch evidence does not prove that no patch exists. Filters below change the event list only.
Loading timeline…
The approach is described in our paper Mapping CVEs to MITRE ATT&CK Techniques: A Curated Gold-Set Classifier and the Limits of LLM-Assisted Label Expansion.
Browse all ATT&CK techniques and the vulnerabilities related to each.
Related by attack behaviour
Vulnerabilities whose description is nearest to this one in the vector space of the CIRCL/vulnerability-attack-technique-biencoder model. This is a similarity search over the bi-encoder space (plain cosine), not a classification, and it has no measured accuracy.